Lercanidipine - CAS 100427-26-7
Catalog number: 100427-26-7
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C36H41N3O6
Molecular Weight:
611.73
COA:
Inquire
Targets:
Calcium Channel
Description:
Lercanidipine hydrochloride, a dihydropyridine compound, is a third generation calcium channel antagonist which shows longer duration of action of the past two generations' in the treatment of mild-to-moderate hypertension.
Publictions citing BOC Sciences Products
  • >> More
Purity:
95%
Appearance:
White to light yellow solid
Synonyms:
Lercanidipine;100427-26-7;Lercanidipine[INN];masnidipine;Lercanil(TN);Lercanidipine(INN)
Solubility:
10 mM in DMSO
Storage:
-20 ºC Freeze
MSDS:
Inquire
Application:
Lercanidipine hydrochloride is a third generation calcium channel antagonist which shows longer duration of action of the past two generations' in the treatment of mild-to-moderate hypertension.
Shelf Life:
As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly
Quantity:
Grams-Kilos
Boiling Point:
712.5ºC at 760 mmHg
Melting Point:
118-120ºC
Density:
1.177 g/cm3
InChIKey:
ZDXUKAKRHYTAKV-UHFFFAOYSA-N
InChI:
InChI=1S/C36H41N3O6/c1-24-31(34(40)44-6)33(28-18-13-19-29(22-28)39(42)43)32(25(2)37-24)35(41)45-36(3,4)23-38(5)21-20-30(26-14-9-7-10-15-26)27-16-11-8-12-17-27/h7-19,22,30,33,37H,20-21,23H2,1-6H3
Canonical SMILES:
CC1=C(C(C(=C(N1)C)C(=O)OC(C)(C)CN(C)CCC(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC(=CC=C4)[N+](=O)[O-])C(=O)OC
1.Development and validation of reversed phase high-performance liquid chromatography method for estimation of lercanidipine HCl in pure form and from nanosuspension formulation.
Chonkar AD1, Managuli RS1, Rao JV2, Udupa N3. J Basic Clin Pharm. 2015 Dec;7(1):17-22. doi: 10.4103/0976-0105.170586.
AIM: Quantitative estimation of lercanidipine HCl in bulk material as well as from nanosuspension formulations via a developed reverse phase HPLC method.
2.Adverse event potentially due to an interaction between ibrutinib and verapamil: a case report.
Lambert Kuhn E1, Levêque D1, Lioure B2, Gourieux B1, Bilbault P3. J Clin Pharm Ther. 2016 Feb;41(1):104-5. doi: 10.1111/jcpt.12355.
WHAT IS KNOWN AND OBJECTIVE: Ibrutinib is a recently approved oral anticancer agent with pharmacokinetics that is very sensitive to metabolic inhibition. We report a serious side effect of ibrutinib potentially attributable to interaction with the moderate CYP3A4 inhibitor verapamil.
3.Development of Fast Dissolving Oral Films Containing Lercanidipine HCl Nanoparticles in Semicrystalline Polymeric Matrix for Enhanced Dissolution and Ex Vivo Permeation.
Chonkar AD1, Venkat Rao J2, Managuli RS1, Mutalik S1, Dengale S3, Jain P2, Udupa N4. Eur J Pharm Biopharm. 2016 Apr 5. pii: S0939-6411(16)30125-4. doi: 10.1016/j.ejpb.2016.04.001. [Epub ahead of print]
Lercanidipine is a vasoselective dihydropyridine calcium antagonist, mainly used for the treatment of hypertension and angina pectoris. However, it suffers from food dependent absorption, poor solubility, low permeability and considerable first pass metabolism, resulting in highly variable and low bioavailability of 10%. Nanoparticles of lercanidipine were incorporated in fast dissolving oral films (FDO) via preparation of nanosuspension by evaporative antisolvent precipitation method. Prepared nanosuspensions were incorporated in FDO without lyophilizing or spray drying. Two nanosuspensions containing PEG 400 and TPGS 1000 as stabilizers, selected further for incorporation in FDO. Physicochemical and mechanical properties of the optimised films were observed to be within acceptance criteria. SEM images as well as FTIR chemical images of oral films show uniform distribution of nano-particles in polymeric matrix. The DSC and XRD results proved the poorly crystalline nature of lercanidipine.
4.Combined mixture-process variable approach: a suitable statistical tool for nanovesicular systems optimization.
Habib BA1, AbouGhaly MH1. Expert Opin Drug Deliv. 2016 Apr 4:1-12. [Epub ahead of print]
OBJECTIVES: This study aims to illustrate the applicability of combined mixture-process variable (MPV) design and modeling for optimization of nanovesicular systems.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Calcium Channel Products


CAS 77-41-8 METHSUXIMIDE

METHSUXIMIDE
(CAS: 77-41-8)

Mesuximide is a succinimide anticonvulsant medication. The therapeutic efficacy of methosuximide is due to its pharmacologically active metabolite, N-desmethylm...

CAS 72803-02-2 Darodipine

Darodipine
(CAS: 72803-02-2)

Darodipine, also known as PY 108-068, is an antagonist of calcium channel.

CAS 91599-74-5 Benidipine HCl

Benidipine HCl
(CAS: 91599-74-5)

Benidipine HCl is a hydrochloride salt form of benidipine which is a dihydropyridine calcium channel blocker.

CAS 33286-22-5 Diltiazem Hydrochloride

Diltiazem Hydrochloride
(CAS: 33286-22-5)

Diltiazem HCl (Tiazac) is a benzothiazepine derivative with vasodilating action due to its antagonism of the actions of the calcium ion in membrane functions.

CAS 103890-78-4 Lacidipine

Lacidipine
(CAS: 103890-78-4)

Lacidipine (Lacipil, Motens) is a L-type calcium channel blocker. Lacidipine (Lacipil, Motens) works by relaxing and opening up the blood vessels.

CAS 123524-52-7 Azelnidipine

Azelnidipine
(CAS: 123524-52-7)

Azelnidipine is a dihydropyridine calcium channel blocker.

CAS 136941-70-3 Calcium channel-modulator-1

Calcium channel-modulator-1
(CAS: 136941-70-3)

A calcium channel modulator that blocks aortic contraction (IC50= 0.8 μM)

CAS 144604-00-2 Diltiazem Malate

Diltiazem Malate
(CAS: 144604-00-2)

Diltiazem is a calcium channel antagonist. It can relax the smooth muscles in the walls of arteries, allow blood to flow more easily, and lower blood pressure. ...

CAS 122647-32-9 Ibutilide Fumarate

Ibutilide Fumarate
(CAS: 122647-32-9)

Ibutilide Fumarate is a Class III antiarrhythmic agent that is indicated for acute cardioconversion of atrial fibrillation and atrial flutter of a recent onset ...

CAS 478296-72-9 Gabapentin enacarbil

Gabapentin enacarbil
(CAS: 478296-72-9)

Gabapentin enacarbil (XP-13512) is a prodrug for the anticonvulsant and analgesic drug gabapentin.

S(-)-BAY K 8644
(CAS: 98625-26-4)

S(-)-BAY K 8644 is an activator of voltage-sensitive L-type calcium channels with positive inotropic, vasoconstrictive and behavioral effects in vivo. It is the...

CAS 99254-95-2 McN5691

McN5691
(CAS: 99254-95-2)

McN5691, an antihypertensive agent, is a voltage-sensitive calcium channel blocker.

CAS 30484-77-6 Flunarizine Dihydrochloride

Flunarizine Dihydrochloride
(CAS: 30484-77-6)

Flunarizine 2HCl is a dihydrochloride salt form which is a calcium channel blocker with a Ki of 68 nM.

CAS 187523-36-0 (R)-(-)-Flindokalner

(R)-(-)-Flindokalner
(CAS: 187523-36-0)

(R)-(-)-BMS 204352 is the less active R-(-)-enantiomer of BMS-204352, which is a positive modulator at neuronal Kv7 channels and calcium-activated K+ channels (...

CAS 212778-82-0 Elpetrigine

Elpetrigine
(CAS: 212778-82-0)

Elpetrigine, also known as GW 273293 and JZP-4, has a blocking effect on calcium channels and potassium channels which has been in clinical bipolar disorders an...

CAS 167221-71-8 Clevidipine Butyrate

Clevidipine Butyrate
(CAS: 167221-71-8)

Clevidipine Butyrate is a dihydropyridine calcium channel blocker, uses as an agent for the reduction of blood pressure.

CAS 89226-50-6 Manidipine

Manidipine
(CAS: 89226-50-6)

Manidipine is a dihydropyridine calcium antagonist with an IC50 of 2.6 nM.

CAS 14663-23-1 Dantrolene Sodium

Dantrolene Sodium
(CAS: 14663-23-1)

Dantrolene Sodium, an inhibitor of calcium channel proteins that markedly suppresses the release of calcium previously sequestered by skeletal, but not cardiac,...

CAS 42399-41-7 Diltiazem

Diltiazem
(CAS: 42399-41-7)

Diltiazem is a nondihydropyridines (non-DHP) calcium channel blocker used in the treatment of hypertension, angina pectoris, and some types of arrhythmia as a p...

CAS 152-11-4 Verapamil HCl

Verapamil HCl
(CAS: 152-11-4)

Verapamil HCl is an L-type calcium channel blocker that is a class IV anti-arrhythmia agent.

Chemical Structure

CAS 100427-26-7 Lercanidipine

Quick Inquiry

Verification code

Featured Items